| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Alexander K C Leung | |
| Kam L Hon | |||
| Steven K Loo | |||
| Wing G G Ng | |||
| P2860 | cites work | Influence of initial treatment modality on long-term control of chronic idiopathic urticaria | Q21132678 |
| The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America | Q22242904 | ||
| Management of Pediatric Urticaria with Review of the Literature on Chronic Spontaneous Urticaria in Children. | Q53824117 | ||
| The prevalence of urticaria in the total population | Q54147101 | ||
| Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria | Q56444281 | ||
| Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids | Q56444282 | ||
| Chronic urticaria - What does the new guideline tell us? | Q56961757 | ||
| Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodies | Q57624893 | ||
| Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes | Q69016278 | ||
| Exercise-induced angioedema and asthma | Q69624222 | ||
| Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients | Q69666892 | ||
| Recurrent urticaria: clinical investigation of 330 patients | Q70787266 | ||
| Urticaria and angioedema | Q71567356 | ||
| The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters | Q73467729 | ||
| Chronic urticaria | Q73651084 | ||
| Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria | Q78016161 | ||
| Urticaria | Q79292575 | ||
| Penile and oral angioedema associated with peanut ingestion | Q79566346 | ||
| Chronic urticaria--which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients | Q79576681 | ||
| Use of alternative medicines by allergic patients in Turkey | Q80804689 | ||
| Epidemiology of urticaria in Spain | Q81029380 | ||
| [Neutrophilic urticaria or urticaria with predominantly neutrophilic inflammatory infiltrate: study of its clinical and histopathologic characteristics and its possible association with rheumatic disease] | Q83808967 | ||
| Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria | Q84758598 | ||
| Clinicopathologic findings in (anti-FcepsilonR1alpha) autoimmune-related chronic urticaria | Q86846342 | ||
| Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment | Q88340652 | ||
| Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study | Q89087181 | ||
| Prevalence of Drugs as Triggers of Exacerbations in Chronic Urticaria | Q89341220 | ||
| Urticaria in children and adolescents: An updated review of the pathogenesis and management | Q90749451 | ||
| "Chronic Urticaria": Recommendations From an Allergist and Immunologist | Q91283583 | ||
| Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes | Q91634199 | ||
| H1-antihistamines for chronic spontaneous urticaria | Q24187983 | ||
| Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations | Q24337484 | ||
| Profile of omalizumab in the treatment of chronic spontaneous urticaria | Q26783158 | ||
| EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria | Q26828824 | ||
| Chronic urticaria in adults: state-of-the-art in the new millennium | Q26849258 | ||
| Approaches to the diagnosis and management of chronic urticaria in children | Q26852686 | ||
| Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic | Q28190794 | ||
| Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome | Q28203639 | ||
| Natural course of physical and chronic urticaria and angioedema in 220 patients | Q28213614 | ||
| Leukotriene receptor antagonists for chronic urticaria: a systematic review | Q33593785 | ||
| Increased Risk of Chronic Spontaneous Urticaria in Patients With Autoimmune Thyroid Diseases: A Nationwide, Population-based Study | Q33734366 | ||
| Urticaria treated with dapsone | Q33870577 | ||
| Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. | Q34035726 | ||
| The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. | Q34147428 | ||
| Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review | Q34183721 | ||
| An update on autoinflammatory diseases | Q34380526 | ||
| Ketotifen in the management of chronic urticaria: resurrection of an old drug | Q34387181 | ||
| Chronic urticaria and autoimmunity | Q34389760 | ||
| Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy | Q34412092 | ||
| Omalizumab in children | Q34604574 | ||
| Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus | Q34761812 | ||
| Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives | Q34771490 | ||
| Treatment of refractory chronic urticaria with sirolimus | Q34986965 | ||
| Autoinflammatory syndromes | Q35810569 | ||
| Urticaria: reassessed | Q35866024 | ||
| Chronic urticaria: pathogenesis and treatment | Q35882288 | ||
| The thyroid and urticaria | Q36244795 | ||
| A stepwise approach in the management of chronic spontaneous urticaria in children | Q36516134 | ||
| Cold-induced urticaria: challenges in diagnosis and management | Q37077765 | ||
| Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes | Q37534954 | ||
| Impact of chronic urticaria on the quality of life of patients followed up at a university hospital. | Q37540414 | ||
| High-dose anti-histamine use and risk factors in children with urticaria | Q37591936 | ||
| Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria | Q47707567 | ||
| CRP, D-dimer, fibrinogen and ESR as predictive markers of response to standard doses of levocetirizine in patients with chronic spontaneous urticaria | Q48017779 | ||
| Acupuncture in patients with seasonal allergic rhinitis: a randomized trial | Q48296355 | ||
| Chronic urticaria and irritable bowel syndrome: a cross-sectional study of 11 271 patients | Q48347036 | ||
| CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients | Q48350939 | ||
| The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update | Q48517489 | ||
| Evaluation of a clinical guideline for the diagnoses of physical and chronic urticaria and angioedema | Q48616704 | ||
| Epidemiology of urticaria: a representative cross-sectional population survey | Q48818614 | ||
| Chronic Urticaria in Children: Still Itching for Insight | Q49651437 | ||
| Acute and Chronic Urticaria: Evaluation and Treatment. | Q50911014 | ||
| Chronic urticaria and autoimmunity: associations found in a large population study. | Q51360062 | ||
| Chronic urticaria: etiology and natural course in children. | Q51461131 | ||
| Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria. | Q51561077 | ||
| Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergológica 2005. | Q51825085 | ||
| Chronic urticaria can be caused by cancer and resolves with its cure. | Q52808234 | ||
| Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series. | Q52866200 | ||
| Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials. | Q52877128 | ||
| Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. | Q37609638 | ||
| Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children | Q37702904 | ||
| Thyroid Autoimmunity in Patients with Chronic Urticaria | Q37719904 | ||
| Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response | Q37811988 | ||
| Targeting interleukin-1β in CAPS (cryopyrin-associated periodic) syndromes: what did we learn? | Q38033872 | ||
| Management of childhood urticaria: current knowledge and practical recommendations | Q38094948 | ||
| Therapy of chronic urticaria: a simple, modern approach | Q38198360 | ||
| The diagnosis and management of acute and chronic urticaria: 2014 update. | Q38207184 | ||
| The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update | Q38208428 | ||
| Urticarial vasculitis and urticarial autoinflammatory syndromes | Q38317536 | ||
| Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines | Q38542586 | ||
| Epidemiology of Chronic Urticaria in Korea Using the Korean Health Insurance Database, 2010-2014. | Q38693457 | ||
| The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU. | Q38764670 | ||
| Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria | Q38861332 | ||
| A Review of International Recommendations for the Diagnosis and Management of Chronic Urticaria | Q38878806 | ||
| Clinical practice guideline for diagnosis and management of urticaria | Q38968988 | ||
| Use of omalizumab in the treatment of chronic urticaria | Q39010294 | ||
| BSACI guideline for the management of chronic urticaria and angioedema | Q39035835 | ||
| Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria | Q39181525 | ||
| A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria | Q39235636 | ||
| Schnitzler Syndrome: a Review | Q39440981 | ||
| Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy | Q40001317 | ||
| Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome | Q40118761 | ||
| Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study | Q40191096 | ||
| Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results). | Q40258551 | ||
| The targeted eosinophil-lowering effects of dexpramipexole in clinical studies | Q40339953 | ||
| Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases | Q40514447 | ||
| Allergic reactions to drugs and biologic agents | Q41660189 | ||
| Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study | Q42236176 | ||
| Checklist for a complete chronic urticaria medical history: an easy tool | Q42369359 | ||
| Effect of arterial hypertension on chronic urticaria duration. | Q43238254 | ||
| Experience with cyclosporine in children with chronic idiopathic urticaria | Q43290172 | ||
| Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity | Q44123873 | ||
| The utility of serum tryptase as a marker in chronic spontaneous urticaria | Q44974443 | ||
| Chronic Idiopathic Urticaria: Systemic Complaints and Their Relationship with Disease and Immune Measures. | Q45054753 | ||
| Measurement of nitric oxide and 8-isoprostane in exhaled breath of children with atopic eczema. | Q45976585 | ||
| What the first 10,000 patients with chronic urticaria have taught me: a personal journey | Q46199108 | ||
| Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease | Q46216607 | ||
| C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. | Q47410715 | ||
| Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study | Q47659668 | ||
| Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients. | Q47698271 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 1 | |
| P921 | main subject | omalizumab | Q415392 |
| chronic urticaria | Q3886240 | ||
| immunologic factor | Q50349184 | ||
| non-sedating histamine H1 antagonist | Q50430305 | ||
| P304 | page(s) | 27-37 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Recent Patents on Inflammation and Allergy Drug Discovery | Q24054843 |
| P1476 | title | Chronic Urticaria: An Overview of Treatment and Recent Patents | |
| P478 | volume | 13 |
| Q98612727 | Helicobacter pylori infection: Beyond gastric manifestations | cites work | P2860 |
Search more.